Scheduled System Maintenance:
On Monday, April 27th, IEEE Xplore will undergo scheduled maintenance from 1:00 PM - 3:00 PM ET (17:00 - 19:00 UTC). No interruption in service is anticipated.
By Topic

MicroRNA expression analysis reveals significant biological pathways in human prostate cancer

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

5 Author(s)
Yifei Tang ; Center for Syst. Biol., Soochow Univ., Suzhou, China ; Jiajia Chen ; Cheng Luo ; Kaipia, A.
more authors

MicroRNAs (miRNAs) are reported to play essential roles in cancer initiation and progression and microarray technologies are intensively applied to study the miRNA expression profile in cancer. It is very common that the set of differentially expressed miRNAs related to the same cancer identified from different laboratories varies widely. Meanwhile, how the altered miRNAs coordinately contribute to the cause of prostate cancer is still not clear. In this study, we collected and processed four human prostate cancer associated miRNA microarray expression datasets with newly developed cancer outlier detection methods to identify differentially expressed miRNAs (DE-miRNAs). The targets of these DE-miRNAs were then extracted from database or predicted by bioinformatics prediction and then mapped to functional databases for enrichment analysis and overlapping comparison. Newly developed outlier detection methods were found to be more appropriate than t-test in cancer research, and the consistency of independent prostate cancer expression profiles at pathway or gene-set level was shown higher than that at gene (i.e. miRNA here) level. Furthermore, we identified 41 Gene Ontology terms, 4 KEGG pathways and 77 GeneGO pathways which are associated with prostate cancer. Among the top 15 GeneGO pathways, 5 were reported previously and the rest could be putative ones. Our analyses showed that more appropriate outlier detection methods should be used to detect oncogenes or oncomiRNAs that are altered only in a subset of samples. We proved that expression signatures of independent microarray experiments are more consistent rather at pathway level than at miRNA / gene level. We also found that the utilization of similar meta-analysis methods between miRNA and mRNA profiling datasets result in the detection of the same pathways.

Published in:

Systems Biology (ISB), 2011 IEEE International Conference on

Date of Conference:

2-4 Sept. 2011